Abstract:OBJECTIVE:Accumulation of free fatty acids (FFAs) in hepatocytes induces lipotoxicity, leading to non-alcoholic fatty liver disease (NAFLD). This study aimed to investigate the underlying mechanisms by which FFA contributes to the pathogenesis of NAFLD via the regulation of 3-mercaptopyruvate sulfurtransferase (MPST), a key enzyme that regulates endogenous hydrogen sulfide (H2S) biosynthesis.DESIGN:Hepatic MPST expression was evaluated in mice and patients with NAFLD. A variety of molecular approaches were used to study the effects of MPST regulation on hepatic steatosis in vivo and in vitro.RESULTS:In vitro treatment of hepatocytes with FFAs upregulated MPST expression, which was partially dependent on NF-κB/p65. Hepatic MPST expression was markedly increased in high fat diet (HFD)-fed mice and patients with NAFLD. Partial knockdown of MPST via adenovirus delivery of MPST short hairpin RNA or heterozygous deletion of the Mpst gene significantly ameliorated hepatic steatosis in HFD-fed mice. Consistently, inhibition of MPST also reduced FFA-induced fat accumulation in L02 cells. Intriguingly, inhibition of MPST significantly enhanced rather than decreased H2S production, whereas MPST overexpression markedly inhibited H2S production. Co-immunoprecipitation experiments showed that MPST directly interacted with and negatively regulated cystathionine γ-lyase (CSE), a major source of H2S production in the liver. Mechanistically, MPST promoted steatosis via inhibition of CSE/H2S and subsequent upregulation of the sterol regulatory element-binding protein 1c pathway, C-Jun N-terminal kinase phosphorylation and hepatic oxidative stress.CONCLUSIONS:FFAs upregulate hepatic expression of MPST and subsequently inhibit the CSE/H2S pathway, leading to NAFLD. MPST may be a potential therapeutic target for NAFLD.

Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth

Suppmentary Materials and Methods and Supplementary Figures 1 Through 6 from Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth

Stabilization of FASN by ACAT1-mediated GNPAT Acetylation Promotes Lipid Metabolism and Hepatocarcinogenesis

Supplemental Figure S5 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Supplemental Figure S4 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Acetylation Stabilizes ATP-citrate Lyase to Promote Lipid Biosynthesis and Tumor Growth.

Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors

Acetate Functions As an Epigenetic Metabolite to Promote Lipid Synthesis under Hypoxia.

Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity

Fatty Acids Promote Fatty Liver Disease Via the Dysregulation of 3-Mercaptopyruvate Sulfurtransferase/hydrogen Sulfide Pathway.

Unsaturated Fatty Acids Stimulate Tumor Growth Through Stabilization of Β‐catenin

USP22-dependent accumulation of lipidomes drives hepatocellular carcinoma progression by stabilizing PPARγ

Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells

Regulation of fatty acid synthase on tumor and progress in the development of related therapies

Targeting Fatty Acid Synthase to Halt Tumor Progression and Enhance Radiosensitivity in Breast Cancer Cells

Fatty Acid Synthase Enhances Colorectal Cancer Cell Proliferation and Metastasis Via Regulating AMPK/mTOR Pathway

Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer

FASN promotes gallbladder cancer progression and reduces cancer cell sensitivity to gemcitabine through PI3K/AKT signaling

Unsaturated Fatty Acids Stimulate Tumor Growth through Stabilization of β-Catenin

Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase.

Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves Mtor Malonylation.